It has earned a five-star rating from Morningstar and ranks in the top 16% of all funds in The expense ratio is 0.85%, which is about a third lower that of the average expense ratio of its The fund may invest in both domestic and foreign companies.įCNTX had a 10-year annualized return of 15.48% compared with its benchmark S&P 500 Index of 10.80%. The fund invests in large-cap stocks-those with market values greater than $10 billion and with growth potential through price appreciation rather than dividend income.
TOP 25 BEST PERFORMING MUTUAL FUNDS FULL
There is also a 0.06% 12b-1 distribution fee.įNCMX has earned a five star rating from Morningstar and ranks in the top 10% of funds in itsĪlly Invest or Vanguard: which is better?įCNTX is a true contrarian fund whereby the manager looks for undervalued stocks and buys those stocks deemed likely to return to their full and fair valuation in the future. It should be noted that FNCMX has a 0.75% fee if shares are sold within 90ĭays of purchase. The expense ratio is about 75% lower than its benchmark'sĪverage expense ratio. The fund's 10-year annualized return is 18.31%, only 17 basis points below its benchmark indexĭespite a net expense ratio of 0.30%. All other factorsīeing equal, the index funds with the lowest expense ratios will outperform those with high expense Total returns won't vary muchīecause the funds are not trading in and out or buying stocks outside the index.
Investing in the same portfolio of stocks and holding those stocks. With index funds, expense ratios are vitally important, because passively-managed index funds are Volatility will be higher than average because Nasdaq stocks are generally small or medium sized. Normally the fund is fully invested, but it may hold up to 20% cash or cash equivalents. Noted that FBIOX charges a 0.75% fee if shares are sold within 30 days of purchase.įidelity NASDAQ Composite Index Fund (FNCMX)įNCMX is a passively-managed index fund that invests in the common stocks of the Nasdaq Composite Index, which is composed of the stocks of more than 5000 domestic and international companies that are listed on the Nasdaq Stock Market. It has earnedĪ four-star rating from Morningstar and ranks in the top 2% of funds in its category. Than doubled the performance of the S&P-500 Index. It outperformed its benchmark indices and more The fund's 10-year annualized return is 21.21%. The stocks tend to be mid-sized growth-oriented companies. The fund may also invest in companies that benefit directly from biotechnology in some way.įBIOX normally invests at least 80% of its assets in these types of companies, and usually invests in common stocks, but may purchase other investments. The fund invests in companies that engage in biotechnological products, services, and processes. Biotechnology in particular is quite volatile, but can produce far above average returns if stocks are carefully selected. It is not surprising that a technology fund is the top Fidelity performer over the last 10 years. Screening for 10-plus years of the same manager running the fund shows how that manager performed during the bear market in 2008-2009Īs well as the past five years of bull market with occasional corrections.įidelity Select Biotechnology Portfolio (FBIOX) Rating from Morningstar, a minimum investment of $2,500, lower-than-average expense ratios when compared to peers, no upfront transactionįees, a fund history of at least 10 years, and a fund manager who has managed the fund for at least 10 years. The list has been filtered to show those with at least a four-star Here are the top 3 best-performingįidelity Funds over the past 10 years. There are more than 200 Fidelity Funds to choose from, so finding a fund that suits your investment needs is easy.įinding a fund that also outperforms most or all of its competitor funds is much more difficult. In the mutual fund world, Fidelity Investments stands at or near the top in terms of assets under management, number of funds offered,Īnd reputation. 2022 list of the best Fidelity mutual funds with top Morningstar ratings.ģ best performing Fidelity mutual funds for IRA/brokerage account investors in the last 10 years: Fidelity Select Biotechnology Portfolio (FBIOX),įidelity NASDAQ Composite Index Fund (FNCMX), and Fidelity Contrafund (FCNTX).
0 kommentar(er)
